Cloning Technology: Control the Bonanza for Research Eggs
By Marcy Darnovsky, Susan Berke Fogel, Judy Norsigian,
Nature
| 12. 01. 2011
[Letter to the editor]
The demand for women’s eggs for research could soar alarmingly following news of a cloning technique that uses human oocytes to reprogram somatic cells to a state of pluripotency (S. Noggle et al. Nature 478, 70–75; 2011).
The mean number of eggs given by each woman during the study was 16.9, with one donating 26 eggs. This is more than many fertility doctors would consider optimal and increases the risk of ovarian hyperstimulation syndrome. The researchers do not say that they halted hormone treatment in cases of over-response, although they did stop it in under-responsive women.
Noggle et al. rightly anticipated concerns that payment for eggs could encourage financially disadvantaged women to take risks they might otherwise avoid. But US$8,000, the amount paid by Noggle and colleagues, would be a temptation even to the well-off in these difficult economic times.
Some argue that women should evaluate for themselves the risks and benefits of providing eggs for research. But informed consent depends on provision of accurate information. Even after years of egg harvesting for fertility treatment, the risks to women —...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...